KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Work In Process (2021)

Ginkgo Bioworks Holdings filings provide 1 years of Work In Process readings, the most recent being $50000.0 for Q4 2021.

  • On a quarterly basis, Work In Process changed N/A to $50000.0 in Q4 2021 year-over-year; TTM through Dec 2021 was $50000.0, a N/A change, with the full-year FY2021 number at $50000.0, changed N/A from a year prior.
  • Work In Process hit $50000.0 in Q4 2021 for Ginkgo Bioworks Holdings, down from $163000.0 in the prior quarter.
  • In the past five years, Work In Process ranged from a high of $163000.0 in Q3 2021 to a low of $50000.0 in Q4 2021.